|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/44 | (2006.01) |
| C07K 16/44 | (2013.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 31/04 | (2018.01) |
| (11) | Number of the document | 3494143 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17751568.1 |
| Date of filing the European patent application | 2017-08-02 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/045183 |
| Date | 2017-08-02 |
| (87) | Number | WO 2018/026969 |
| Date | 2018-02-08 |
| (30) | Number | Date | Country code |
| 201662370580 P | 2016-08-03 | US |
| (72) |
BENDER, Kristina, Oresic , US
HENRY, Christopher, E. , US
THEOLIS, Richard , US
WU, Shuang , US
|
| (73) |
Cipla USA, Inc. ,
10 Independence Boulevard Suite 300, Warren NJ 07059,
US
|
| (54) | PLAZOMICIN ANTIBODIES AND METHODS OF USE |
| PLAZOMICIN ANTIBODIES AND METHODS OF USE |